AbbVie
ABBV
#26
Rank
C$490.63 B
Marketcap
$277.64
Share price
-0.50%
Change (1 day)
45.17%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Cash on Hand

Cash on Hand as of June 2024 : C$18.31 Billion

According to AbbVie's latest financial reports the company has C$18.31 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AbbVie - Cash on Hand chart (from 2011 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$16.99 B35.74%
2022-12-31C$12.52 B-0.04%
2021-12-31C$12.52 B15.88%
2020-12-31C$10.81 B-79.27%
2019-12-31C$52.14 B374.86%
2018-12-31C$10.98 B-10.78%
2017-12-31C$12.30 B42.58%
2016-12-31C$8.63 B-25.99%
2015-12-31C$11.66 B20.01%
2014-12-31C$9.71 B-7.74%
2013-12-31C$10.53 B32.81%
2012-12-31C$7.93 B1094.06%
2011-12-31C$0.66 B6067.03%
2010-12-31C$10.77 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$9.88 B-46.03%๐Ÿ‡บ๐Ÿ‡ธ USA
C$11.26 B-38.48%๐Ÿ‡บ๐Ÿ‡ธ USA
C$4.89 B-73.26%๐Ÿ‡บ๐Ÿ‡ธ USA
C$12.54 B-31.51%๐Ÿ‡บ๐Ÿ‡ธ USA
C$3.85 B-78.93%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.65 B-85.49%๐Ÿ‡บ๐Ÿ‡ธ USA
C$5.98 B-67.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$9.84 B-46.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$1.70 B-90.67%๐Ÿ‡บ๐Ÿ‡ธ USA